AptarGroup Inc (ATR)

Currency in USD
157.14
+0.35(+0.22%)
Closed·
After Hours
158.31+1.17(+0.74%)
·
ATR Scorecard
Full Analysis
Has raised its dividend for 32 consecutive years
ATR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
155.18157.35
52 wk Range
130.85178.03
Key Statistics
Prev. Close
156.79
Open
155.78
Day's Range
155.18-157.35
52 wk Range
130.85-178.03
Volume
667.96K
Average Volume (3m)
356.52K
1-Year Change
7.57%
Book Value / Share
38.47
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ATR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
176.83
Upside
+12.53%
Members' Sentiments
Bearish
Bullish
ProTips
2 analysts have revised their earnings downwards for the upcoming period

AptarGroup Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

AptarGroup Inc Company Profile

AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments. It also provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions. In addition, the company offers dispensing pumps, closures, elastomeric components, aerosol valves, and digital health solutions. It primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.

Employees
13500

AptarGroup Inc SWOT Analysis


Pharma Powerhouse
AptarGroup's Pharma division shows significant momentum, particularly in biologics, offsetting challenges in other segments and driving overall growth
Financial Fortitude
Strong balance sheet with low debt and consistent performance positions AptarGroup for potential acquisitions and shareholder returns
Market Dynamics
Explore how AptarGroup navigates consumer spending fluctuations and raw material costs while maintaining its competitive edge in packaging solutions
Future Trajectory
Analysts project double-digit earnings growth, with price targets ranging from $168 to $170, driven by innovation in drug delivery systems
Read full SWOT analysis

AptarGroup Inc Earnings Call Summary for Q1/2025

  • AptarGroup Q1 2025: EPS $1.20 beats $1.16 forecast; revenue $887M misses $929.07M estimate; stock up 0.34% after-hours
  • Pharma segment core sales up 3%; flat overall core sales; adjusted EBITDA grew 3% YoY to $183M; free cash flow $26M
  • Q2 2025 guidance: EPS $1.56-$1.64, tax rate 19-21%; long-term Pharma growth target 7-11%; new product launches planned
  • CEO highlights resilience amid economic uncertainty; focus on essential products; analysts query inventory destocking, GLP-1 demand
  • Risks: supply chain disruptions, market saturation, macroeconomic pressures, tariff changes, cold/cough market inventory destocking
Last Updated: 02/05/2025, 15:08
Read Full Transcript

Compare ATR to Peers and Sector

Metrics to compare
ATR
Peers
Sector
Relationship
P/E Ratio
27.8x14.4x2.4x
PEG Ratio
1.610.210.00
Price/Book
4.1x1.1x1.6x
Price / LTM Sales
2.9x1.1x1.3x
Upside (Analyst Target)
11.7%10.7%22.1%
Fair Value Upside
Unlock9.2%3.1%Unlock

Analyst Ratings

5 Buy
2 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 176.83
(+12.53% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 5.58%
Dividend Yield
1.15%
Industry Median 2.42%
Annualised payout
1.80
Paid quarterly
5-Years Growth
+4.10%
Growth Streak

Earnings

Latest Release
Jul 31, 2025
EPS / Forecast
1.66 / 1.59
Revenue / Forecast
966.00M / 952.15M
EPS Revisions
Last 90 days

ATR Income Statement

People Also Watch

112.92
PHM
-0.39%
57.27
ROL
-0.64%
326.80
HEI
+0.48%
112.18
LEN
-0.17%
106.51
APH
+0.97%

FAQ

What Stock Exchange Does AptarGroup Trade On?

AptarGroup is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for AptarGroup?

The stock symbol for AptarGroup is "ATR."

What Is the AptarGroup Market Cap?

As of today, AptarGroup market cap is 10.33B.

What Is AptarGroup's Earnings Per Share (TTM)?

The AptarGroup EPS (TTM) is 5.58.

When Is the Next AptarGroup Earnings Date?

AptarGroup will release its next earnings report on 29 Oct 2025.

From a Technical Analysis Perspective, Is ATR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has AptarGroup Stock Split?

AptarGroup has split 2 times.

How Many Employees Does AptarGroup Have?

AptarGroup has 13500 employees.

What is the current trading status of AptarGroup (ATR)?

As of 01 Aug 2025, AptarGroup (ATR) is trading at a price of 157.14, with a previous close of 156.79. The stock has fluctuated within a day range of 155.18 to 157.35, while its 52-week range spans from 130.85 to 178.03.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.